Skip to main content
. 2014 Sep 1;8:1675–1679. doi: 10.2147/OPTH.S68243

Figure 4.

Figure 4

Infrared photos captured prior to initiating anti-vascular endothelial growth factor therapy (bevacizumab) and at last follow-up.

Note: Images show no progression of choroidal/retinal pigment epithelium atrophy during the course of treatment.